Cancer Research Network
The Baptist Health Cancer Research Network is a collaborative effort among physicians, nurses, patients, caregivers, and administrators who work tirelessly to improve cancer care at Baptist Health through research.
Cancer research at Baptist Health has grown tremendously in the last 20 years with continued growth expected through the collaboration of the Baptist Health Cancer Research Network. Baptist Health has wholeheartedly supported research efforts mirroring the mission to provide the latest treatments and technologies to treat our cancer patients. One of the things that makes our program unique among community research sites is that it has always been hospital-based and has enhanced our ability to provide patients with NCI-sponsored, cooperative-group studies, culminating in our recent designation as a Main Member for NRG and GRN.
For more information about the Network, please contact:
Baptist Health Cancer Research Network
Ms. Micheal Stephens, Program Director
1720 Nicholasville Road, Suite 703
Lexington, Kentucky 40503
Frequently Asked Questions
The Baptist Health hospitals in Lexington and Louisville have offered clinical trials sponsored by the National Cancer Institute (NCI) as separate entities for over 20 years. In 2014 Baptist Health embarked on a mission to expand research opportunities to all communities across the state.
Baptist Health Lexington and Baptist Health Louisville have now combined efforts with the other Baptist Health hospitals to bring the same large, NCI-sponsored trials to all Kentuckians. The Baptist Health Cancer Research Network became recognized as a “main member” (parent site) by the NCI in April 2015. NCI adult cancer trial sites are categorized as a main member “parent” site or an affiliate site which reports to the parent site.
This expansion brings advanced treatment to people where they live. Besides Lexington and Louisville, clinical studies will now be available in and close to communities where Baptist Health owns hospitals, as well as Elizabethtown, where Baptist Health manages Hardin Memorial Health.
The BHCRN promises even greater strides by bringing together physician leaders and key research administrators through the Baptist Health Cancer Research Council. The council will select trials based on patient population and physician interest, develop a quality monitoring system to assure compliance with National Cancer Institute guidelines and ensure proper researcher training.
The Baptist Health Cancer Research Network offers a variety of Phase II, Phase III and quality-of-life trials – for a variety of cancers, including breast, lung and lymphoma.
Phase II trials look at effectiveness, safety and potential side effects.
Phase III trials continue to look at safety and potential side effects, but the real question researchers are trying to answer for the U.S. Food and Drug Administration (FDA) in this phase is whether the treatment being studied is better than the standard treatment.
Baptist Health hospitals have a long history of participating in clinical trial research.
Approximately 200 research studies are ongoing at Baptist Health hospitals, focusing on oncology, cardiology, orthopedics, neuroscience, pulmonary conditions, gynecology, nursing and allied health, among others.